|
summary: This preliminary study looked at the effects of Protiramer, a new medicine similar to Copaxone, in treating people with MS. They found that brain inflammation measured with MRI was reduced and it was safe. Further, larger studies are now needed.
authors: De Stefano N, Filippi M, Confavreux C, Vermersch P, Simu M, Sindic C, Hupperts R, Bajenaru O, Edan G, Grimaldi L, Marginean I, Medaer R, Orefice G, Pascu I, Pelletier J, Sanders E, Scarpini E, Mancardi G
source: Mult Scler. 2008 Nov 5. [Epub ahead of print]
weblink: click here
category: Clinical Trials and Therapeutics
related research news: click here
glossary:
Axon
Brain
Inflammation
Magnetic Resonance Imaging (MRI)
Multiple sclerosis
Relapsing/remitting MS
Sclerosis
|
